Takara

Results: 1034



#Item
11

PDF Document

Add to Reading List

Source URL: www.takara-bio.co.jp

- Date: 2016-08-22 20:41:01
    12

    PDF Document

    Add to Reading List

    Source URL: www.takara-dental.jp

    - Date: 2018-05-29 04:29:14
      13https://www.takara-dic-net.jp/xeditor_ne/xeditor_edit/Xbrl/Edit

      https://www.takara-dic-net.jp/xeditor_ne/xeditor_edit/Xbrl/Edit

      Add to Reading List

      Source URL: chitaya07.xsrv.jp

      Language: Japanese - Date: 2016-04-27 20:57:24
        14f  Coordinatrice marketing Maeva CRAMBERT, promotion 2011 Takara Bio Europe - de 2012 à 2013

        f Coordinatrice marketing Maeva CRAMBERT, promotion 2011 Takara Bio Europe - de 2012 à 2013

        Add to Reading List

        Source URL: www.supbiotech.fr

        Language: French - Date: 2017-12-21 11:45:13
          15https://www.takara-dic-net.jp/xeditor_ne/xeditor_web/html_gene.

          https://www.takara-dic-net.jp/xeditor_ne/xeditor_web/html_gene.

          Add to Reading List

          Source URL: www.osakakoshinko.co.jp

          Language: Japanese - Date: 2017-05-15 03:02:06
            16Final Results of a Phase II Multicenter Trial of HF10, a Replication-competent HSV-1 Oncolytic Virus, and Ipilimumab Combination Treatment in Patients with Stage IIIB-IV Unresectable or Metastatic Melanoma Abstract #1664

            Final Results of a Phase II Multicenter Trial of HF10, a Replication-competent HSV-1 Oncolytic Virus, and Ipilimumab Combination Treatment in Patients with Stage IIIB-IV Unresectable or Metastatic Melanoma Abstract #1664

            Add to Reading List

            Source URL: www.takara-bio.co.jp

            Language: English - Date: 2017-06-02 05:25:57
              17Tumor response from Phase II study of combination treatment of intratumoral HF10, a replication - competent HSV-1 oncolytic virus, and ipilimumab in patients with stage IIIB, IIIC, or IV unresectable or metastatic melano

              Tumor response from Phase II study of combination treatment of intratumoral HF10, a replication - competent HSV-1 oncolytic virus, and ipilimumab in patients with stage IIIB, IIIC, or IV unresectable or metastatic melano

              Add to Reading List

              Source URL: www.takara-bio.co.jp

              Language: English - Date: 2016-10-24 01:27:48
                18https://www.takara-dic-net.jp/xeditor_ne/xeditor_web/html_gene.

                https://www.takara-dic-net.jp/xeditor_ne/xeditor_web/html_gene.

                Add to Reading List

                Source URL: www.osakakoshinko.co.jp

                Language: Japanese - Date: 2017-05-15 03:02:10
                  19お客様各位 水銀使用製品に関 する お知らせ タカラベルモント 株式 会社 デンタル事業部  日頃は当社製品 をご 愛顧いただき誠に あり がとうございます 。

                  お客様各位 水銀使用製品に関 する お知らせ タカラベルモント 株式 会社 デンタル事業部 日頃は当社製品 をご 愛顧いただき誠に あり がとうございます 。

                  Add to Reading List

                  Source URL: www.takara-dental.jp

                  Language: Japanese - Date: 2018-05-29 04:29:21
                    20https://www.takara-dic-net.jp/xeditor_ne/xeditor_edit/Xbrl/Edit

                    https://www.takara-dic-net.jp/xeditor_ne/xeditor_edit/Xbrl/Edit

                    Add to Reading List

                    Source URL: chitaya07.xsrv.jp

                    Language: Japanese - Date: 2016-04-27 21:05:56